palmitoylethanolamide.com.au
HomeResearchOana 2022

Intrapersonal Stability of Plasma Metabolomic Profiles over 10 Years among Women

Oana A Zeleznik, Clemens Wittenbecher, Amy Deik, Sarah Jeanfavre, Julian Avila-Pacheco, Bernard Rosner, Kathryn M Rexrode, Clary B Clish, Frank B Hu, A Heather Eliassen. Metabolites. 2022 Apr 20;12(5):372.

Observational studyHumans

Design
Observational study
Subjects
1,880 women (1,184 repeated samples) in the primary dataset and 1,456 women (488 repeated samples) in the secondary dataset, Nurses' Health Study
Dose used in the study
Not stated in the abstract; no treatment was given
Duration
Samples donated about 10 years apart
What was measured
Within-person stability (intra-class correlation) of 5,938 plasma metabolites and metabolite features over 10 years

What the authors reported

The study found:

  • Median ICC was 0.43 for known metabolites.
  • The most stable were N6,N6-dimethyllysine (0.82), dimethylguanidino valerate (0.72) and N-acetylornithine (0.72).
  • The least stable were palmitoylethanolamide (ICC = 0.05), ectoine (0.09) and trimethylamine-N-oxide (0.16).
  • Results in the secondary dataset were similar.

Limits of this study

A biomarker stability study in women; it measured natural blood palmitoylethanolamide and did not test PEA as a treatment. The low PEA stability means a single blood measurement poorly reflects a person's long-term level. The authors declare no conflict of interest.

Source

PubMed 35629875 · doi:10.3390/metabo12050372

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.